Tigagrelor is an antiplatelet medication used to prevent blood clots. However, during the manufacturing process, impurities may be formed which can potentially harm the efficacy and safety of the drug. Tigagrelor impurities can include chemical compounds, metals, and other substances that are not supposed to be present in the drug. Strict quality control measures are necessary to ensure the purity of Tigagrelor and minimize the risks of adverse effects on patients.
![2-(((3aR,4S,6S,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol](https://structures.clearsynth.com/2----3aR-4S-6S-6aS--6-Amino-2-2-dimethyltetrahydro-3aH-cyclopenta-d--1-3-dioxol-4-yl-oxy-ethanol.png "Tigagrelor Impurities")